Chemiluminescent Immunoassay (CLIA)

Sekbio Co., Ltd

Shenzhen, China

Sekbio Co., Ltd., dedicated to high-performance antibodies discovery and manufacturing. With proven expertise in innovative biomarker antibody development, Sekbio transforms scientific insight into scalable diagnostic solutions. Powered by our proprietary CHO cell line technology, Sekbio ensures consistent productivity and exceptional antibody quality, delivering gram-scale quantities for commercial and diagnostic use. Backed by dozens of successful IVD antibody development cases, we are recognized for our precision in antibody engineering, cell line development, and efficient tech transfer from R D to production. Our flexible expression systems, including transient and stable platforms, allow rapid customization and high-yield production. Certified under ISO 13485 and supported by state-of-the-art cleanroom facilities, Sekbio s quality management ensures global compliance and dependable performance. Collaborating closely with Sun Yat-sen University (SYSU), we continuously expand our pipeline with cutting-edge biomarkers such as MxA, HPV oncoprotein antibodies, sandwich vitamin D antibodies, and Chitinase-3-like-1. These innovations have advanced multiple diagnostic assays worldwide. Sekbio s end-to-end capabilities—from antibody discovery and recombinant protein design to CDMO services—empower partners with robust, ready-to-commercialize solutions. Trusted by over 100 IVD brands globally, Sekbio stands as your reliable partner in accelerating innovative biomarker development and advancing next-generation diagnostic excellence.